These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 28535963

  • 1. Usefulness of 11C-methionine-PET for predicting the efficacy of carbon ion radiation therapy for head and neck mucosal malignant melanoma.
    Hasebe M, Yoshikawa K, Nishii R, Kawaguchi K, Kamada T, Hamada Y.
    Int J Oral Maxillofac Surg; 2017 Oct; 46(10):1220-1228. PubMed ID: 28535963
    [Abstract] [Full Text] [Related]

  • 2. Accuracy of methionine-PET in predicting the efficacy of heavy-particle therapy on primary adenoid cystic carcinomas of the head and neck.
    Toubaru S, Yoshikawa K, Ohashi S, Tanimoto K, Hasegawa A, Kawaguchi K, Saga T, Kamada T.
    Radiat Oncol; 2013 Jun 13; 8():143. PubMed ID: 23758795
    [Abstract] [Full Text] [Related]

  • 3. A study on the prognostic evaluation of carbon ion radiotherapy for head and neck adenocarcinoma with C-11 methionine PET.
    Hasebe M, Yoshikawa K, Ohashi S, Toubaru S, Kawaguchi K, Sato J, Mizoe J, Tsujii H.
    Mol Imaging Biol; 2010 Oct 13; 12(5):554-62. PubMed ID: 20369300
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography/computed tomography for outcome of carbon ion radiotherapy in patients with head and neck mucosal malignant melanoma.
    Inubushi M, Saga T, Koizumi M, Takagi R, Hasegawa A, Koto M, Wakatuki M, Morikawa T, Yoshikawa K, Tanimoto K, Fukumura T, Yamada S, Kamada T.
    Ann Nucl Med; 2013 Jan 13; 27(1):1-10. PubMed ID: 22914968
    [Abstract] [Full Text] [Related]

  • 5. 11C-methionine-PET for evaluation of carbon ion radiotherapy in patients with pelvic recurrence of rectal cancer.
    Koizumi M, Saga T, Yoshikawa K, Suzuki K, Yamada S, Hasebe M, Ohashi S, Abd-Elrazek S, Ishikawa H, Sagou K, Tamura K, Hara R, Kato H, Yasuda S, Yanagi T, Tsujii H.
    Mol Imaging Biol; 2008 Jan 13; 10(6):374-80. PubMed ID: 18679757
    [Abstract] [Full Text] [Related]

  • 6. Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.
    Yanagawa T, Saito K, Kiyohara H, Ohno T, Nakano T, Takagishi K.
    Radiat Oncol; 2015 Dec 21; 10():259. PubMed ID: 26691334
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography.
    Nuutinen J, Jyrkkiö S, Lehikoinen P, Lindholm P, Minn H.
    Radiother Oncol; 1999 Sep 21; 52(3):225-32. PubMed ID: 10580868
    [Abstract] [Full Text] [Related]

  • 8. [S-methyl-11C]-L-methionine positron emission tomography/computed tomography imaging parameters to evaluate early response for esophageal cancer with neoadjuvant carbon ion radiotherapy.
    Narushima K, Nishii R, Okazumi S, Shimada H, Akutsu Y, Maeda T, Yasuda S, Yamada S, Shuto K, Tamura K, Yamazaki K, Shinoto M, Ishikawa H, Mori M, Matsubara H.
    Sci Rep; 2022 Aug 11; 12(1):13694. PubMed ID: 35953702
    [Abstract] [Full Text] [Related]

  • 9. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy.
    Yanagi T, Mizoe JE, Hasegawa A, Takagi R, Bessho H, Onda T, Kamada T, Okamoto Y, Tsujii H.
    Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):15-20. PubMed ID: 19046826
    [Abstract] [Full Text] [Related]

  • 10. Clinical target volume design and dose in carbon-ion radiation therapy for sinonasal mucosal melanoma.
    Yang WC, Koto M, Ikawa H, Imai R, Shinoto M, Takiyama H, Isozaki T, Yamada S.
    Radiother Oncol; 2024 Nov 01; 200():110511. PubMed ID: 39216826
    [Abstract] [Full Text] [Related]

  • 11. Carbon-11-methionine positron emission tomography imaging of chordoma.
    Zhang H, Yoshikawa K, Tamura K, Sagou K, Tian M, Suhara T, Kandatsu S, Suzuki K, Tanada S, Tsujii H.
    Skeletal Radiol; 2004 Sep 01; 33(9):524-30. PubMed ID: 15483754
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of post-treatment metabolic tumor volume from 11C-methionine PET/CT in recurrent malignant glioma.
    Jung TY, Min JJ, Bom HS, Jung S, Kim IY, Lim SH, Kim DY, Kwon SY.
    Neurosurg Rev; 2017 Apr 01; 40(2):223-229. PubMed ID: 27282449
    [Abstract] [Full Text] [Related]

  • 13. Particle therapy for mucosal melanoma of the head and neck. A single-institution retrospective comparison of proton and carbon ion therapy.
    Demizu Y, Fujii O, Terashima K, Mima M, Hashimoto N, Niwa Y, Akagi T, Daimon T, Murakami M, Fuwa N.
    Strahlenther Onkol; 2014 Feb 01; 190(2):186-91. PubMed ID: 24362502
    [Abstract] [Full Text] [Related]

  • 14. Radiation therapy for mucosal melanoma of the head and neck.
    Christopherson K, Malyapa RS, Werning JW, Morris CG, Kirwan J, Mendenhall WM.
    Am J Clin Oncol; 2015 Feb 01; 38(1):87-9. PubMed ID: 23563215
    [Abstract] [Full Text] [Related]

  • 15. [Clinical characteristic and prognostic analyses of 117 cases of head and neck mucosal melanoma].
    Yin GF, Guo W, Chen XH, Liu ZY, Huang ZG.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Sep 07; 53(9):668-674. PubMed ID: 30293258
    [Abstract] [Full Text] [Related]

  • 16. Feasibility of Re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy.
    Hayashi K, Koto M, Ikawa H, Hagiwara Y, Tsuji H, Ogawa K, Kamada T.
    Radiother Oncol; 2019 Jul 07; 136():148-153. PubMed ID: 31015117
    [Abstract] [Full Text] [Related]

  • 17. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
    Lin P, Min M, Lee M, Holloway L, Forstner D, Bray V, Fowler A.
    Eur J Nucl Med Mol Imaging; 2017 May 07; 44(5):801-811. PubMed ID: 28004135
    [Abstract] [Full Text] [Related]

  • 18. Optimization of scan initiation timing after 11C-methionine administration for the diagnosis of suspected recurrent brain tumors.
    Nakajima R, Abe K, Momose M, Fukushima K, Matsuo Y, Kimura K, Kondo C, Sakai S.
    Ann Nucl Med; 2017 Feb 07; 31(2):190-197. PubMed ID: 27885545
    [Abstract] [Full Text] [Related]

  • 19. [(11)C]methionine positron emission tomography and survival in patients with bone and soft tissue sarcomas treated by carbon ion radiotherapy.
    Zhang H, Yoshikawa K, Tamura K, Tomemori T, Sagou K, Tian M, Kandatsu S, Kamada T, Tsuji H, Suhara T, Suzuki K, Tanada S, Tsujii H.
    Clin Cancer Res; 2004 Mar 01; 10(5):1764-72. PubMed ID: 15014030
    [Abstract] [Full Text] [Related]

  • 20. 18F-FDG PET/CT and histology for diagnosing recurrent/remnant tumors in head and neck cancer patients treated with radiotherapy.
    Han EJ, O JH, Yoo IR, Kim YS, Kim MS, Kang JH, Choi WH.
    Hell J Nucl Med; 2017 Mar 01; 20(2):134-140. PubMed ID: 28697190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.